IL6 and COVID-19: Among biomarkers linked to disease severity in elderly COVID-19 patients, interleukin-6 (IL-6)—a pro-inflammatory cytokine—plays a key role and has also been associated with the progression of frailty (Promislow and Anderson, 2020; Wang et al., 2020).